Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 11 | 2024 | 1103 | 3.370 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 358 | 2.270 |
Why?
|
| Colorectal Neoplasms | 4 | 2024 | 441 | 2.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2024 | 208 | 1.810 |
Why?
|
| Electronic Health Records | 7 | 2023 | 66 | 1.420 |
Why?
|
| SEER Program | 7 | 2024 | 91 | 1.330 |
Why?
|
| Registries | 5 | 2021 | 335 | 1.040 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 1502 | 1.010 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 494 | 0.990 |
Why?
|
| Medicare | 3 | 2024 | 195 | 0.930 |
Why?
|
| Housing | 1 | 2024 | 59 | 0.920 |
Why?
|
| Humans | 56 | 2024 | 37093 | 0.910 |
Why?
|
| Social Class | 2 | 2022 | 247 | 0.860 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 37 | 0.850 |
Why?
|
| Hospitals | 7 | 2015 | 86 | 0.820 |
Why?
|
| United States | 14 | 2024 | 4223 | 0.790 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 88 | 0.780 |
Why?
|
| California | 9 | 2022 | 476 | 0.760 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 404 | 0.710 |
Why?
|
| Female | 37 | 2024 | 20969 | 0.700 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 137 | 0.690 |
Why?
|
| Aged | 22 | 2024 | 6741 | 0.680 |
Why?
|
| Maternal Exposure | 1 | 2018 | 33 | 0.630 |
Why?
|
| Death Certificates | 1 | 2018 | 12 | 0.630 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 61 | 0.590 |
Why?
|
| Mexican Americans | 1 | 2019 | 189 | 0.580 |
Why?
|
| Aged, 80 and over | 12 | 2024 | 2379 | 0.580 |
Why?
|
| Premature Birth | 1 | 2018 | 75 | 0.580 |
Why?
|
| Incidence | 8 | 2022 | 922 | 0.570 |
Why?
|
| Smoking | 3 | 2022 | 940 | 0.570 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 126 | 0.570 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 336 | 0.570 |
Why?
|
| Male | 25 | 2024 | 20025 | 0.550 |
Why?
|
| Selection Bias | 2 | 2022 | 11 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 643 | 0.510 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 935 | 0.500 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 16 | 0.490 |
Why?
|
| Health Status Disparities | 5 | 2021 | 642 | 0.490 |
Why?
|
| Sex Factors | 5 | 2024 | 898 | 0.480 |
Why?
|
| Quality Assurance, Health Care | 4 | 2015 | 56 | 0.470 |
Why?
|
| Middle Aged | 21 | 2024 | 10129 | 0.470 |
Why?
|
| Patient Compliance | 1 | 2014 | 212 | 0.440 |
Why?
|
| Adult | 22 | 2023 | 11712 | 0.430 |
Why?
|
| Melanoma | 1 | 2013 | 96 | 0.410 |
Why?
|
| Age of Onset | 2 | 2021 | 100 | 0.390 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 159 | 0.390 |
Why?
|
| Age Factors | 4 | 2024 | 1033 | 0.380 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 277 | 0.380 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 4 | 0.380 |
Why?
|
| Lighting | 1 | 2010 | 12 | 0.380 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 730 | 0.370 |
Why?
|
| Geological Phenomena | 1 | 2010 | 4 | 0.360 |
Why?
|
| Occupational Diseases | 1 | 2010 | 47 | 0.360 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2020 | 8 | 0.360 |
Why?
|
| Geologic Sediments | 1 | 2010 | 42 | 0.360 |
Why?
|
| Rivers | 1 | 2010 | 44 | 0.350 |
Why?
|
| Phosphorus | 1 | 2010 | 68 | 0.340 |
Why?
|
| Cross-Cultural Comparison | 2 | 2014 | 107 | 0.340 |
Why?
|
| Retrospective Studies | 5 | 2023 | 2026 | 0.330 |
Why?
|
| Risk Factors | 6 | 2021 | 3562 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 145 | 0.320 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 190 | 0.310 |
Why?
|
| Water | 1 | 2010 | 296 | 0.300 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 275 | 0.260 |
Why?
|
| Survival Rate | 2 | 2019 | 311 | 0.260 |
Why?
|
| Safety Management | 2 | 2015 | 18 | 0.250 |
Why?
|
| Endometrial Neoplasms | 2 | 2015 | 66 | 0.240 |
Why?
|
| Marital Status | 1 | 2024 | 40 | 0.240 |
Why?
|
| Critical Pathways | 2 | 2014 | 15 | 0.240 |
Why?
|
| Forecasting | 1 | 2024 | 128 | 0.230 |
Why?
|
| Epidemiologic Methods | 1 | 2023 | 49 | 0.220 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 10 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 198 | 0.220 |
Why?
|
| Air Pollution | 1 | 2023 | 60 | 0.220 |
Why?
|
| Teaching | 1 | 2003 | 55 | 0.220 |
Why?
|
| Hospital Administration | 4 | 2015 | 9 | 0.220 |
Why?
|
| Europe | 7 | 2015 | 101 | 0.210 |
Why?
|
| Air Pollutants | 1 | 2023 | 94 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2022 | 48 | 0.210 |
Why?
|
| Prejudice | 1 | 2003 | 110 | 0.210 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2003 | 80 | 0.210 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2022 | 9 | 0.210 |
Why?
|
| Hallucinogens | 1 | 2022 | 28 | 0.210 |
Why?
|
| Comorbidity | 1 | 2024 | 623 | 0.200 |
Why?
|
| Marijuana Smoking | 1 | 2022 | 85 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 78 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 160 | 0.190 |
Why?
|
| Poverty | 1 | 2024 | 348 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 864 | 0.190 |
Why?
|
| Mortality | 2 | 2019 | 145 | 0.190 |
Why?
|
| Age Distribution | 1 | 2021 | 225 | 0.190 |
Why?
|
| Cannabis | 1 | 2022 | 79 | 0.190 |
Why?
|
| Veterans | 1 | 2022 | 122 | 0.190 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 8 | 0.180 |
Why?
|
| Population Surveillance | 1 | 2021 | 238 | 0.180 |
Why?
|
| South America | 1 | 2019 | 15 | 0.170 |
Why?
|
| Cuba | 1 | 2019 | 32 | 0.170 |
Why?
|
| Cross-Sectional Studies | 9 | 2022 | 2721 | 0.170 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 6 | 0.160 |
Why?
|
| Clinical Competence | 2 | 2014 | 130 | 0.160 |
Why?
|
| Mammography | 2 | 2024 | 188 | 0.160 |
Why?
|
| Quality Control | 2 | 2015 | 36 | 0.160 |
Why?
|
| Organizational Culture | 2 | 2015 | 14 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 28 | 0.160 |
Why?
|
| Aortic Diseases | 1 | 2018 | 27 | 0.160 |
Why?
|
| Cause of Death | 2 | 2018 | 156 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 46 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2018 | 112 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 268 | 0.150 |
Why?
|
| Medical Staff, Hospital | 2 | 2015 | 13 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 87 | 0.150 |
Why?
|
| Young Adult | 6 | 2021 | 4268 | 0.150 |
Why?
|
| Contracts | 1 | 2016 | 1 | 0.140 |
Why?
|
| Patient Participation | 2 | 2015 | 75 | 0.140 |
Why?
|
| Drug Synergism | 1 | 2017 | 177 | 0.140 |
Why?
|
| Internet | 2 | 2016 | 211 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 935 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2016 | 76 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2016 | 215 | 0.140 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 441 | 0.130 |
Why?
|
| Mental Health | 1 | 2019 | 303 | 0.130 |
Why?
|
| Hospital Charges | 1 | 2015 | 13 | 0.130 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 3 | 0.130 |
Why?
|
| Reward | 1 | 2016 | 79 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 23 | 0.130 |
Why?
|
| Hysterectomy | 1 | 2015 | 28 | 0.130 |
Why?
|
| Patients | 1 | 2015 | 14 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2015 | 54 | 0.130 |
Why?
|
| Logistic Models | 2 | 2017 | 923 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2018 | 894 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2020 | 1378 | 0.130 |
Why?
|
| San Francisco | 1 | 2014 | 32 | 0.130 |
Why?
|
| Binomial Distribution | 1 | 2014 | 1 | 0.120 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2014 | 23 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2013 | 325 | 0.120 |
Why?
|
| Occult Blood | 1 | 2014 | 29 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 39 | 0.120 |
Why?
|
| Health Status | 2 | 2018 | 380 | 0.120 |
Why?
|
| Puerto Rico | 1 | 2019 | 1378 | 0.120 |
Why?
|
| Probability | 1 | 2014 | 78 | 0.120 |
Why?
|
| Hospital Administrators | 1 | 2014 | 2 | 0.120 |
Why?
|
| Communication Barriers | 1 | 2014 | 56 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 885 | 0.120 |
Why?
|
| Proxy | 1 | 2014 | 7 | 0.120 |
Why?
|
| Checklist | 1 | 2014 | 13 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 13 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2015 | 210 | 0.120 |
Why?
|
| Colonoscopy | 1 | 2014 | 104 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 45 | 0.120 |
Why?
|
| Nurses | 1 | 2014 | 48 | 0.120 |
Why?
|
| Gene Expression | 1 | 2017 | 674 | 0.120 |
Why?
|
| Developed Countries | 1 | 2013 | 12 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 40 | 0.120 |
Why?
|
| Birth Rate | 1 | 2013 | 5 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 128 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2024 | 1492 | 0.110 |
Why?
|
| Maternal Mortality | 1 | 2013 | 13 | 0.110 |
Why?
|
| Child Mortality | 1 | 2013 | 7 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 664 | 0.110 |
Why?
|
| Exercise | 1 | 2019 | 613 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 63 | 0.110 |
Why?
|
| Cultural Competency | 1 | 2014 | 131 | 0.110 |
Why?
|
| Leadership | 1 | 2013 | 76 | 0.110 |
Why?
|
| Language | 1 | 2014 | 157 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 57 | 0.110 |
Why?
|
| Developing Countries | 1 | 2013 | 99 | 0.110 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 32 | 0.110 |
Why?
|
| Pregnancy | 1 | 2018 | 1549 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1067 | 0.110 |
Why?
|
| Prognosis | 3 | 2022 | 739 | 0.110 |
Why?
|
| Austria | 1 | 2012 | 4 | 0.110 |
Why?
|
| Motivation | 1 | 2016 | 436 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 664 | 0.110 |
Why?
|
| Causality | 1 | 2012 | 44 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 626 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 68 | 0.100 |
Why?
|
| Research Design | 1 | 2014 | 313 | 0.100 |
Why?
|
| Physicians | 1 | 2014 | 163 | 0.100 |
Why?
|
| Educational Status | 1 | 2013 | 313 | 0.100 |
Why?
|
| Indoles | 1 | 2013 | 158 | 0.100 |
Why?
|
| Health Behavior | 1 | 2014 | 537 | 0.090 |
Why?
|
| Health Promotion | 1 | 2016 | 653 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2012 | 753 | 0.090 |
Why?
|
| Adolescent | 4 | 2022 | 5363 | 0.080 |
Why?
|
| Texas | 1 | 2010 | 324 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 225 | 0.080 |
Why?
|
| Time Factors | 2 | 2023 | 1742 | 0.070 |
Why?
|
| Hip Fractures | 2 | 2015 | 23 | 0.070 |
Why?
|
| European Union | 2 | 2014 | 5 | 0.060 |
Why?
|
| Turkey | 2 | 2014 | 22 | 0.060 |
Why?
|
| North Carolina | 1 | 2024 | 104 | 0.060 |
Why?
|
| New Zealand | 1 | 2003 | 21 | 0.060 |
Why?
|
| Particulate Matter | 1 | 2023 | 51 | 0.060 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 225 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 75 | 0.050 |
Why?
|
| Nomograms | 1 | 2022 | 9 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 38 | 0.050 |
Why?
|
| Obesity | 1 | 2010 | 1067 | 0.050 |
Why?
|
| Breast | 1 | 2023 | 135 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2014 | 550 | 0.050 |
Why?
|
| Stroke | 2 | 2015 | 286 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2018 | 1418 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2003 | 339 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2023 | 216 | 0.050 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 16 | 0.050 |
Why?
|
| Curriculum | 1 | 2003 | 265 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2020 | 61 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 9 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2023 | 1130 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 462 | 0.040 |
Why?
|
| Public Opinion | 1 | 2019 | 17 | 0.040 |
Why?
|
| Happiness | 1 | 2019 | 12 | 0.040 |
Why?
|
| Censuses | 1 | 2019 | 24 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 93 | 0.040 |
Why?
|
| Semantics | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cities | 1 | 2019 | 63 | 0.040 |
Why?
|
| Aortography | 1 | 2018 | 10 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 27 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 43 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 20 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 465 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 217 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 227 | 0.040 |
Why?
|
| Lymphedema | 1 | 2015 | 8 | 0.030 |
Why?
|
| Urinary Tract | 1 | 2015 | 8 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 5 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 27 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 39 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 16 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2015 | 7 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 40 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 37 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1046 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 61 | 0.030 |
Why?
|
| Robotics | 1 | 2015 | 41 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 145 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 223 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2014 | 4 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 185 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2014 | 31 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2015 | 104 | 0.030 |
Why?
|
| Physician's Role | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 219 | 0.030 |
Why?
|
| Maternal Welfare | 1 | 2013 | 7 | 0.030 |
Why?
|
| Population Growth | 1 | 2013 | 8 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2014 | 84 | 0.030 |
Why?
|
| Suicide | 1 | 2015 | 118 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 194 | 0.030 |
Why?
|
| Africa | 1 | 2013 | 76 | 0.030 |
Why?
|
| Goals | 1 | 2013 | 30 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 2013 | 4 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 276 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 455 | 0.030 |
Why?
|
| Health Policy | 1 | 2013 | 165 | 0.030 |
Why?
|
| Health Surveys | 1 | 2013 | 373 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 534 | 0.030 |
Why?
|
| Eating | 1 | 2013 | 166 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 434 | 0.020 |
Why?
|
| Child | 1 | 2018 | 3131 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 169 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 485 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1455 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3483 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 2303 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 15081 | 0.010 |
Why?
|